Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia.

Parisi, Muriel S; Oliveri, Beatriz; Mautalen, Carlos A

Parisi, Muriel S; Oliveri, Beatriz; Mautalen, Carlos A.

Affiliation

Parisi MS; Sección Osteopatías Médicas, Hospital de Clínicas, Universidad de Buenos Aires, Av. Córdoba 2351, 8(o) piso, 1120, Buenos Aires, Argentina. osteologia@ciudad.com.ar

Bone ; 33(4): 582-8, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14555262

Subject(s)

Bone Density/drug effects; Diphosphonates/administration & dosage; Fibrous Dysplasia of Bone/drug therapy; Fibrous Dysplasia of Bone/metabolism; Adolescent; Adult; Alkaline Phosphatase/blood; Case-Control Studies; Collagen/urine; Collagen Type I; Diphosphonates/adverse effects; Female; Humans; Infusions, Intravenous; Male; Pamidronate; Peptides/urine

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Density / Diphosphonates / Fibrous Dysplasia of Bone Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Bone Journal subject: METABOLISMO / ORTOPEDIA Year: 2003 Type: Article Affiliation country: Argentina

Search on Google

XML

PubMed Links